Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dean

Showing results (21-30 of 248) with videos related to

Pageof 25
Sort By:
NPJ Schizophrenia|September 15, 2021
Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer's disease and cognitionBrian Dean, Elizabeth Scarr
Journal of Neurochemistry|October 30, 2008
Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?Elizabeth Scarr, Brian Dean
Expert Review of Neurotherapeutics|December 24, 2008
Role of the cholinergic system in the pathology and treatment of schizophreniaElizabeth Scarr, Brian Dean
Frontiers in Cellular Neuroscience|December 19, 2013
Mapping the pathophysiology of schizophrenia: interactions between multiple cellular pathwaysChao Deng, Brian Dean
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 13, 2024
Common changes in rat cortical gene expression after antidepressant drug treatment: Impacts on metabolism of polyamines, mRNA splicing, regulation of RAS by GAPs, neddylation and GPCR ligand bindingBrian Dean, Elizabeth Scarr
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 9, 2016
COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortexBrian Dean, Elizabeth Scarr
Current Pharmaceutical Design|January 29, 2016
The Cholinergic System: An Emerging Drug Target for SchizophreniaAndrew Gibbons, Brian Dean
Psychiatry Research|July 18, 2021
Lower levels of tubulin alpha 1b in the frontal pole in schizophrenia supports a role for changed cytoskeletal dynamics in the aetiology of the disorderMegan Snelleksz, Brian Dean
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Altered neuronal markers following treatment with mood stabilizer and antipsychotic drugs indicate an increased likelihood of neurotransmitter releaseElizabeth Scarr, Brian Dean
Biochemical Pharmacology|July 18, 2006
Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosisAvril Pereira, Brian Dean
Pageof 25

Showing results (21-30 of 248) with videos related to

Sort By:
Pageof 25
NPJ Schizophrenia|September 15, 2021
Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer's disease and cognitionBrian Dean, Elizabeth Scarr
Journal of Neurochemistry|October 30, 2008
Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?Elizabeth Scarr, Brian Dean
Expert Review of Neurotherapeutics|December 24, 2008
Role of the cholinergic system in the pathology and treatment of schizophreniaElizabeth Scarr, Brian Dean
Frontiers in Cellular Neuroscience|December 19, 2013
Mapping the pathophysiology of schizophrenia: interactions between multiple cellular pathwaysChao Deng, Brian Dean
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 13, 2024
Common changes in rat cortical gene expression after antidepressant drug treatment: Impacts on metabolism of polyamines, mRNA splicing, regulation of RAS by GAPs, neddylation and GPCR ligand bindingBrian Dean, Elizabeth Scarr
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 9, 2016
COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortexBrian Dean, Elizabeth Scarr
Current Pharmaceutical Design|January 29, 2016
The Cholinergic System: An Emerging Drug Target for SchizophreniaAndrew Gibbons, Brian Dean
Psychiatry Research|July 18, 2021
Lower levels of tubulin alpha 1b in the frontal pole in schizophrenia supports a role for changed cytoskeletal dynamics in the aetiology of the disorderMegan Snelleksz, Brian Dean
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Altered neuronal markers following treatment with mood stabilizer and antipsychotic drugs indicate an increased likelihood of neurotransmitter releaseElizabeth Scarr, Brian Dean
Biochemical Pharmacology|July 18, 2006
Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosisAvril Pereira, Brian Dean
Pageof 25